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3D suspension culture enables scale-up of human pluripotent stem cell (hPSC) manufacturing. However, media 
and methods optimized for 2D adherent cultures can lead to low volumetric productivity and laborious workflow 
in suspension cultures. To overcome these limitations we developed fed-batch media based on either 
mTeSRTM1 (BSA-containing) or TeSRTM-E8TM (animal component-free) for hPSC expansion as aggregates in 
suspension cultures. Fed-batch feeding protocols are more efficient and cost-effective than batch media 
changes because only exhausted components are replenished.  Optimization studies were performed using 
human embryonic (H7 and H9), and human induced pluripotent (WLS-1C and STiPS-M001) stem cell lines. 
Suspension cultures were fed daily using either 50% medium exchanges of standard 2D media, or fed-batch 
optimized media and protocols. hPSC aggregate diameter must be kept below 350 μm to maintain cell viability 
and phenotype.  With observed growth rates, aggregates required passaging every 3 or 4 days into clumps of 5-
10 cells with Gentle Cell Dissociation Reagent. Clumps were re-seeded into fresh test medium plus 10 μM Y-
27632. Passaging and feeding cycles were repeated for at least 5 passages. Optimization was performed by 
iteratively modifying the feed solution to maintain consistent nutrient levels and maximal growth rate while 
maintaining cell quality. Control and optimized fed-batch formulations demonstrated between 1.4 and 1.8-fold 
expansion per day, >90% viability, Oct4 and TRA-1-60 expression >90%, in vitro trilineage differentiation, and 
normal karyotype (n=8 independent cultures). Suspension culture optimized mTeSRTM-3D or TeSRTM-E8TM3D 
fed-batch media enables the cost-effective production of hPSCs as aggregates with efficient workflow and high 
cell quality.   
 
 
